* Researchers found that most samples contained IgM, IgG, and IgA anti-LPS antibodies, with a notable increase in activity for infections and non-infections, as opposed to malignant conditions.
* The findings suggest that measuring anti-LPS NAbs in pleural fluid can help differentiate between benign and malignant PEs, highlighting their potential clinical relevance.